Zhenmin Bai

Zhenmin Bai

Auto-generated profile, based on publicly available information

Zhenmin Bai

School of Sports Medicine and Rehabilitation Beijing Sport University Beijing People's Republic of China

Research Focus & Metrics

Academic Career Length

2Years (2025-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 October 2025 in Journal of Pain Research
Verified
Journal Article
Open access
PDF file
FZFenglin Zhu
Fenglin Zhu
YCYetong Chen
Yetong Chen
YZYang Zhu
Yang Zhu
ZBZhenmin Bai
Zhenmin Bai
HYHuiping Yan
Huiping Yan
Background: Extremity musculoskeletal pain (EMP) is a major contributor to chronic pain and disability worldwide, often involving tendinopathies, enthesopathies, and myofascial pain syndromes. Conventional treatments such as medications, injections, and physical therapy frequently provide only partial or short-term relief. Acupuncture, widely practiced in clinical settings, has been proposed as a safe and effective alternative or adjunctive therapy. Methods: A comprehensive search of PubMed, Embase, and the Cochrane Library identified studies published from January 2015 to June 2024. Eligible publications included randomized controlled trials (RCTs), systematic reviews, or meta-analyses involving adults with EMP and reporting pain or function as primary outcomes. Nineteen studies (10 RCTs, 9 reviews) met the inclusion criteria and were narratively synthesized. Results: For lateral epicondylitis (LE), manual acupuncture provided short-term benefit, while dry needling demonstrated superior long-term effects. Evidence for carpal tunnel syndrome (CTS) was insufficient, with mixed findings and high risk of bias. In patellofemoral pain syndrome (PFPS), trigger point dry needling showed short-to-medium term pain relief, though its added value in multimodal therapy was inconsistent. For plantar heel pain syndrome (PHPS), both electroacupuncture and dry needling produced significant improvements in pain and function, with benefits sustained beyond three months. Conclusion: Acupuncture appears to be a safe, low-risk therapy for EMP, with strongest evidence for PHPS and LE, limited support for PFPS, and insufficient evidence for CTS. Clinically, acupuncture should be considered as part of comprehensive multimodal strategies, tailored to patient needs and preferences. Future research should focus on large-scale, standardized RCTs, direct comparisons between acupuncture modalities, and inclusion of regional and non-English studies to strengthen the global evidence base.

1 June 2025 in Journal of Pain Research
Verified
Journal Article
Open access
PDF file
YCYetong Chen
Yetong Chen
FZFenglin Zhu
Fenglin Zhu
YZYang Zhu
Yang Zhu
YDYucheng Duan
Yucheng Duan
ZBZhenmin Bai
Zhenmin Bai
Purpose: Motion style acupuncture treatment (MSAT) is a new treatment which comprises acupuncture therapy and exercise therapy. Musculoskeletal pain is highly prevalent and a significant contributor to global disability and disease. In recent years, an increasing number of studies have applied MSAT to the management of musculoskeletal pain. This scoping review systematically collected clinical studies on the use of MSAT in the management of different musculoskeletal pain conditions and identified any adverse events. Methods: Seven databases were searched from their inception through to 2024. RCTs and CCTs on MSAT for pain conditions meeting the inclusion criteria were identified. Data were extracted on patients, interventions, details of MSAT, control treatments and outcomes. Results: This review included 36 clinical studies. These included, 27 (75%) RCTs and 9 (25%) CCTs, treating 2620 patients with 16 different pain-related diseases or symptoms. The most frequently reported conditions were acute lumbar sprain (8, 22.22%), adhesive capsulitis (5, 13.89%). Selection of movement and acupuncture was different in the treatment of different musculoskeletal pain conditions. MSAT was used alone in about one-third of the studies and of the remaining studies it was combined with other treatment. All studies reported relevant outcomes of pain and 9 (25%) adverse events. Conclusion: MSAT, which seems to be a promising intervention used in the management of diverse musculoskeletal pain conditions, has been gradually studied in China and Korea. However, given the variety of study designs and reported treatment outcomes, conclusions about the evidence for MSAT for specific conditions are not possible at this stage.